BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37032554)

  • 1. A Simplified Version of the IASLC Grading System for Invasive Pulmonary Adenocarcinomas With Improved Prognosis Discrimination.
    Bossé Y; Gagné A; Althakfi WA; Orain M; Couture C; Trahan S; Pagé S; Joubert D; Fiset PO; Desmeules P; Joubert P
    Am J Surg Pathol; 2023 Jun; 47(6):686-693. PubMed ID: 37032554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the novel International Association for the Study of Lung Cancer grading system and prognostic value of filigree micropapillary and discohesive growth pattern in invasive pulmonary adenocarcinoma.
    Zhang Y; Zhang Y; Hu Y; Zhang S; Zhu M; Hu B; Guo X; Lu J; Zhang Y
    Lung Cancer; 2023 Jan; 175():79-87. PubMed ID: 36481678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-grade tumor classified by new system is a prognostic predictor in resected lung adenocarcinoma.
    Yoshida C; Yokomise H; Ibuki E; Go T; Haba R; Kadota K
    Gen Thorac Cardiovasc Surg; 2022 May; 70(5):455-462. PubMed ID: 35050467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical database study in the TKIs era in Korea.
    Woo W; Yang YH; Cha YJ; Moon DH; Shim HS; Cho A; Kim BJ; Kim HE; Park BJ; Lee JG; Kim DJ; Paik HC; Lee S; Lee CY
    Thorac Cancer; 2022 Dec; 13(23):3310-3321. PubMed ID: 36345148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation Study of the International Association for the Study of Lung Cancer Histologic Grading System of Invasive Lung Adenocarcinoma.
    Rokutan-Kurata M; Yoshizawa A; Ueno K; Nakajima N; Terada K; Hamaji M; Sonobe M; Menju T; Date H; Morita S; Haga H
    J Thorac Oncol; 2021 Oct; 16(10):1753-1758. PubMed ID: 33905897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation Study of New IASLC Histology Grading System in Stage I Non-Mucinous Adenocarcinoma Comparing With Minimally Invasive Adenocarcinoma.
    Woo W; Cha YJ; Kim BJ; Moon DH; Lee S
    Clin Lung Cancer; 2022 Nov; 23(7):e435-e442. PubMed ID: 35945128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frozen sections accurately predict the IASLC proposed grading system and prognosis in patients with invasive lung adenocarcinomas.
    Fan J; Yao J; Si H; Xie H; Ge T; Ye W; Chen J; Yin Z; Zhuang F; Xu L; Su H; Zhao S; Xie X; Zhao D; Wu C; Zhu Y; Ren Y; Xu N; Chen C;
    Lung Cancer; 2023 Apr; 178():123-130. PubMed ID: 36822017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee.
    Moreira AL; Ocampo PSS; Xia Y; Zhong H; Russell PA; Minami Y; Cooper WA; Yoshida A; Bubendorf L; Papotti M; Pelosi G; Lopez-Rios F; Kunitoki K; Ferrari-Light D; Sholl LM; Beasley MB; Borczuk A; Botling J; Brambilla E; Chen G; Chou TY; Chung JH; Dacic S; Jain D; Hirsch FR; Hwang D; Lantuejoul S; Lin D; Longshore JW; Motoi N; Noguchi M; Poleri C; Rekhtman N; Tsao MS; Thunnissen E; Travis WD; Yatabe Y; Roden AC; Daigneault JB; Wistuba II; Kerr KM; Pass H; Nicholson AG; Mino-Kenudson M
    J Thorac Oncol; 2020 Oct; 15(10):1599-1610. PubMed ID: 32562873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micropapillary and solid components as high-grade patterns in IASLC grading system of lung adenocarcinoma: Clinical implications and management.
    Mikubo M; Tamagawa S; Kondo Y; Hayashi S; Sonoda D; Naito M; Shiomi K; Ichinoe M; Satoh Y
    Lung Cancer; 2024 Jan; 187():107445. PubMed ID: 38157805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new IASLC grading system for invasive non-mucinous lung adenocarcinoma is a more useful indicator of patient survival compared with previous grading systems.
    Yanagawa N; Sugai M; Shikanai S; Sugimoto R; Osakabe M; Uesugi N; Saito H; Maemondo M; Sugai T
    J Surg Oncol; 2023 Jan; 127(1):174-182. PubMed ID: 36098331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel insights into the International Association for the Study of Lung Cancer grading system for lung adenocarcinoma.
    Tan KS; Reiner A; Emoto K; Eguchi T; Takahashi Y; Aly RG; Rekhtman N; Adusumilli PS; Travis WD
    Mod Pathol; 2024 May; ():100520. PubMed ID: 38777035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposal of a revised International Association for the Study of Lung Cancer grading system in pulmonary non-mucinous adenocarcinoma: The importance of the lepidic proportion.
    Park BJ; Woo W; Cha YJ; Shim HS; Yang YH; Moon DH; Kim BJ; Kim HE; Kim DJ; Paik HC; Lee JG; Lee S; Lee CY
    Lung Cancer; 2023 Jan; 175():1-8. PubMed ID: 36436241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implication of the 2020 International Association for the Study of Lung Cancer histologic grading in surgically resected pathologic stage 1 lung adenocarcinomas: Prognostic value and association with computed tomography characteristics.
    Cho IS; Shim HS; Lee HJ; Suh YJ
    Lung Cancer; 2023 Oct; 184():107345. PubMed ID: 37611496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposed novel grading system for stage I invasive lung adenocarcinoma and a comparison with the 2020 IASLC grading system.
    Wang S; Li Y; Sun X; Dong J; Liu L; Liu J; Chen R; Li F; Chen T; Li X; Xie G; Ying J; Guo Q; Mao Y; Yang L
    Thorac Cancer; 2024 Mar; 15(7):519-528. PubMed ID: 38273667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Novel International Association for the Study of Lung Cancer Grading System for Invasive Pulmonary Adenocarcinoma and Association With Common Driver Mutations.
    Deng C; Zheng Q; Zhang Y; Jin Y; Shen X; Nie X; Fu F; Ma X; Ma Z; Wen Z; Wang S; Li Y; Chen H
    J Thorac Oncol; 2021 Oct; 16(10):1684-1693. PubMed ID: 34302987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.
    Warth A; Muley T; Meister M; Stenzinger A; Thomas M; Schirmacher P; Schnabel PA; Budczies J; Hoffmann H; Weichert W
    J Clin Oncol; 2012 May; 30(13):1438-46. PubMed ID: 22393100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IASLC Proposed Grading System Accurately Predicts Prognosis and Mediastinal Nodal Metastasis in Patients With Clinical Stage I Lung Adenocarcinoma.
    Xu L; Su H; Hou L; Wang F; Xie H; She Y; Gao J; Zhao S; Dai C; Xie D; Zhu Y; Wu C; Zhao D; Chen C;
    Am J Surg Pathol; 2022 Dec; 46(12):1633-1641. PubMed ID: 36224092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of pattern-based grading system by the new IASLC/ATS/ERS classification in Asian patients with stage I lung adenocarcinoma.
    Zhao ZR; Xi SY; Li W; Situ DR; Chen KM; Yang H; Su XD; Lin YB; Long H
    Lung Cancer; 2015 Dec; 90(3):604-9. PubMed ID: 26547801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and predictive value of the newly proposed grading system of invasive pulmonary adenocarcinoma in Chinese patients: a retrospective multicohort study.
    Hou L; Wang T; Chen D; She Y; Deng J; Yang M; Zhang Y; Zhao M; Zhong Y; Ma M; Zhao G; Chen Y; Xie D; Zhu Y; Chen Q; Wu C; Chen C;
    Mod Pathol; 2022 Jun; 35(6):749-756. PubMed ID: 35013526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonpredominant lepidic pattern correlates with better outcome in invasive lung adenocarcinoma.
    Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Lappi-Blanco E; Kaarteenaho R
    Lung Cancer; 2015 Dec; 90(3):568-74. PubMed ID: 26506915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.